Weight Management Articles - Page 61

Nutrition & Lifestyle Guidance for GLP-1 Medications with Dietician Diana Reid

Following up on real mom experiences with GLP-1 medications, dietician Diana Reid reveals the hidden pitfalls beyond the 'magic wand' hype. From the beach ball metaphor for body set points to essential protein and strength training, learn how to support your body properly. This balanced guide covers benefits like reduced food noise and risks like hair thinning for informed decisions.

Shotlee·Feb 27, 2026·5 min read

Medication Safety

UK Mounjaro Warning: Counterfeit Pens – Check Batch Numbers

The UK's MHRA has issued a critical warning about counterfeit Mounjaro pens following reports from Eli Lilly. These fake pens contain tirzepatide but may not be sterile, posing potential health risks. Patients are urged to verify batch numbers and report suspicions to the Yellow Card scheme.

Shotlee·Feb 27, 2026·5 min read

GLP-1 Medications

Eli Lilly's Orforglipron: More Effective GLP-1 Pill for Weight Loss?

Eli Lilly's investigational GLP-1 pill, orforglipron, demonstrated greater weight loss and blood sugar control than oral semaglutide in a major phase 3 trial for type 2 diabetes. Patients lost 6-8% body weight compared to 4-5%, though with higher GI side effects. This could signal a shift toward more effective oral therapies.

Shotlee·Feb 26, 2026·6 min read

Health Insurance Policy

States Step In to Make Obamacare Plans More Affordable After Subsidy Expiration

With federal Obamacare subsidies expired, premiums have surged, but ten states are stepping in with their own aid to keep coverage affordable. New Mexico fully replaces the gap for all incomes, while others target low earners amid cost pressures from GLP-1 drugs like Ozempic and Wegovy. Enrollment trends vary, with some states seeing gains despite national drops.

Shotlee·Feb 26, 2026·6 min read

GLP-1 Impact on Food Industry

Benefit-Stacking in Bakery: Ardent Mills Targets GLP-1 Demands

GLP-1 medications are reshaping bakery demands, driving growth in high-fiber, high-protein products. Ardent Mills is leading with benefit-stacking strategies using UltraGrain flour and chickpea ingredients to support satiety and digestive health for users. This guide details the research, innovations, and future outlook.

Shotlee·Feb 26, 2026·6 min read

Metabolic Health

IFT on GLP-1 Formulation: Tailoring Functional Foods to Close Nutrition Gaps

As GLP-1 medications surge in popularity, the Institute of Food Technologists (IFT) is guiding brands on functional foods to fill nutrition gaps. From Danone’s Oikos Fusion yogurt to fiber-woven snacks by Lasso, discover how proteins, prebiotics, and micronutrients support satiety and muscle health for users.

Shotlee·Feb 26, 2026·5 min read

GLP-1 Medications

Zydus Launches Affordable Semaglutide Brands in India on Patent Expiry

Zydus Lifesciences is set to launch affordable semaglutide injections in India right on patent expiry, targeting the growing Type 2 diabetes and obesity crisis. With innovative reusable pens under brands like SEMAGLYN, MASHEMA, and ALTERME, the company aims to cut costs and improve patient adherence. This move could transform access to GLP-1 therapy for millions.

Shotlee·Feb 26, 2026·6 min read

GLP-1 Medications & Weight Management

Tanmay Bhat on GLP-1 Drugs Failing Appetite Suppression & Genetic Report

Comedian Tanmay Bhat recently opened up about his disappointing experience with GLP-1 medications, reporting zero appetite suppression despite using them for weight management. He attributes this to a BDNF gene variant affecting satiety signaling, sparking discussions on genetic factors in treatment response. While many see benefits from drugs like semaglutide and tirzepatide, Bhat's story highlights why results vary.

Shotlee·Feb 26, 2026·5 min read

GLP-1 Medications

Ozempic-Like Drugs in India May Drop 50% in Price from March 2026

Semaglutide-based weight-loss drugs like Ozempic and Wegovy are set for a price revolution in India, with generics launching after patent expiry on March 20, 2026, potentially halving costs. Domestic giants like Sun Pharmaceutical and Dr. Reddy's are gearing up to make these GLP-1 therapies more affordable amid rising obesity rates. This shift could transform access to effective treatments for diabetes and weight management.

Shotlee·Feb 26, 2026·5 min read

Weight Management

Latest Articles

Nutrition & Lifestyle Guidance for GLP-1 Medications with Dietician Diana Reid

UK Mounjaro Warning: Counterfeit Pens – Check Batch Numbers

Eli Lilly's Orforglipron: More Effective GLP-1 Pill for Weight Loss?

States Step In to Make Obamacare Plans More Affordable After Subsidy Expiration

Benefit-Stacking in Bakery: Ardent Mills Targets GLP-1 Demands

IFT on GLP-1 Formulation: Tailoring Functional Foods to Close Nutrition Gaps

Zydus Launches Affordable Semaglutide Brands in India on Patent Expiry

Tanmay Bhat on GLP-1 Drugs Failing Appetite Suppression & Genetic Report

Ozempic-Like Drugs in India May Drop 50% in Price from March 2026

People Taking GLP-1 Weight Loss Drugs Like Ozempic and Wegovy Started Moving Less

Ozempic, Mounjaro & More: Yale Study Exposes Risky Online GLP-1 Prescribing

GLP-1 Drugs Linked to Skin Pain: New Reports of Dysesthesia & Allodynia

Beyond Healthspan: The New Midlife Goal for Men

Ozempic and Similar Weight-Loss Medications Linked to 30% Lower Breast Cancer Risk